Akero Therapeutics, Inc.Akero Therapeutics, Inc.Akero Therapeutics, Inc.

Akero Therapeutics, Inc.

No trades
See on Supercharts

Price target

46.780.00 0.00%
The 9 analysts offering 1 year price forecasts for AKRO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to AKRO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

AKRO EPS for the last quarter is −0.90 USD despite the estimation of −0.90 USD. In the next quarter EPS is expected to reach −0.89 USD. Track more of Akero Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Akero Therapeutics, Inc. revenue is expected to reach 0 USD. Check out Akero Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, AKRO price target is 46.78 USD with a max estimate of 60.00 USD and a min estimate of 30.00 USD. Check if this forecast comes true in a year, meanwhile watch Akero Therapeutics, Inc. stock price chart and keep track of the current situation with AKRO news and stock market news.
We've gathered opinions of 10 analysts rating AKRO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.